Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study.
Koziar Vašáková M, Gregor J, Mogulkoc N, Kramer MR, Lewandowska K, Šterclová M, Müller V, Slivka R, Studnicka M, Plačková M, Žurková M, Tekavec-Trkanjec J, Doubková M, Ovesná P; EMPIRE investigators.
Koziar Vašáková M, et al. Among authors: kramer mr.
Respir Med. 2024 Nov-Dec;234:107791. doi: 10.1016/j.rmed.2024.107791. Epub 2024 Sep 8.
Respir Med. 2024.
PMID: 39255912